To read more on this topic click here.
Can a digital pen “revolutionise” Parkinson’s diagnosis?
News
Author: Sophie BatesPublished: 23 January 2020
Prep:
Cook:
Serves:

A Parkinson’s diagnosing pen has sealed a five-year manufacturing deal from stationery brand Stabilo.
The Neuromotor Pen– developed by Scottish medical devices company Manus Neurodynamica – analyses a user’s hand and limb movements as they perform a number of drawing tests on a tablet.
Microchips within the device record the data of even the smallest of movements, and determine whether a user has Parkinson’s in a simple and non-invasive way.
Researchers believe the pen could be adapted in the future for use in monitoring patients with Alzheimer’s, multiple sclerosis and those that have suffered from a stroke.
Peter Kämpf, director of research and development at Schwan-Stabilo, said: “This novel product can potentially revolutionise the diagnosis and treatment of neuromotor diseases, and we are excited to be involved in its development and in helping bring it to market.”
For more information on Parkinson’s and assessment tools please visit the EPDA website.
Read more:
Scotland sees soaring Parkinson’s rate
Over a quarter of people living with Parkinson’s were initially misdiagnosed, study finds
Last Month
Next Month
Share this story
Related articles

Interviews
“Since being diagnosed with Parkinson’s, my world has expanded”
The latest in our monthly series profiling WPC2019 bloggers
READ MORE
Health & Fitness
From Nordic walking to boxing: six sports for Parkinson’s disease
Find out how exercise can help manage symptoms
READ MORE
Advances
App improves adherence to Parkinson’s meds
Patients using app are "10% more likely to take meds on time"
READ MORE
Comments